Clinical Trial Update: Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis. [Phase 2]

View source ↗

Summary

A Phase 2 safety and preliminary efficacy study of an anti-inflammatory antibody to reduce restenosis after repeat peripheral artery revascularization has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Anti-inflammatory therapeutic antibody (study drug)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Patients Undergoing Repeat Peripheral Artery Revascularization | Phase 2 | Status: COMPLETED